C. Erten Et Al. , "Cisplatin Plus Gemcitabine for Treatment of Breast Cancer Patients with Brain Metastases; a Preferential Option for Triple Negative Patients?," ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , vol.14, no.6, pp.3711-3717, 2013
Erten, C. Et Al. 2013. Cisplatin Plus Gemcitabine for Treatment of Breast Cancer Patients with Brain Metastases; a Preferential Option for Triple Negative Patients?. ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , vol.14, no.6 , 3711-3717.
Erten, C., DEMİR, L., Somali, I., Alacacioglu, A., Kucukzeybek, Y., Akyol, M., ... Can, A.(2013). Cisplatin Plus Gemcitabine for Treatment of Breast Cancer Patients with Brain Metastases; a Preferential Option for Triple Negative Patients?. ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , vol.14, no.6, 3711-3717.
Erten, Cigdem Et Al. "Cisplatin Plus Gemcitabine for Treatment of Breast Cancer Patients with Brain Metastases; a Preferential Option for Triple Negative Patients?," ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , vol.14, no.6, 3711-3717, 2013
Erten, Cigdem Et Al. "Cisplatin Plus Gemcitabine for Treatment of Breast Cancer Patients with Brain Metastases; a Preferential Option for Triple Negative Patients?." ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , vol.14, no.6, pp.3711-3717, 2013
Erten, C. Et Al. (2013) . "Cisplatin Plus Gemcitabine for Treatment of Breast Cancer Patients with Brain Metastases; a Preferential Option for Triple Negative Patients?." ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , vol.14, no.6, pp.3711-3717.
@article{article, author={Cigdem Erten Et Al. }, title={Cisplatin Plus Gemcitabine for Treatment of Breast Cancer Patients with Brain Metastases; a Preferential Option for Triple Negative Patients?}, journal={ASIAN PACIFIC JOURNAL OF CANCER PREVENTION}, year=2013, pages={3711-3717} }